In the current study, we demonstrated that knockdown of circMAP2K2 increases CD4+CD25+Foxp3+ Tregs both in vitro and in vivo, indicating these DCs are associated with immunosuppression or immune tolerance and they could be used to treat immune overeactive diseases such as organ transplantation and autoimmune diseases. Here, FOXP3 is linked to autoimmune disease.